These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7537230)

  • 1. Evidence for multiple interacting binding sites in bovine tryptase.
    Fiorucci L; Erba F; Coletta M; Ascoli F
    FEBS Lett; 1995 Apr; 363(1-2):81-4. PubMed ID: 7537230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization and interaction of bovine pancreatic trypsin inhibitor and tryptase in the granules of bovine mast cells.
    Fiorucci L; Erba F; Falasca L; Dini L; Ascoli F
    Biochim Biophys Acta; 1995 Apr; 1243(3):407-13. PubMed ID: 7537103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cDNA cloning and primary structure of tryptase from bovine mast cells, and evidence for the expression of bovine pancreatic trypsin inhibitor mRNA in the same cells.
    Pallaoro M; Gambacurta A; Fiorucci L; Mignogna G; Barra D; Ascoli F
    Eur J Biochem; 1996 Apr; 237(1):100-5. PubMed ID: 8620861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human mast cell tryptase by benzamidine derivatives.
    Stürzebecher J; Prasa D; Sommerhoff CP
    Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH dependence of bovine mast cell tryptase catalytic activity and of its inhibition by 4',6-diamidino-2-phenylindole.
    Fiorucci L; Erba F; Bolognesi M; Coletta M; Ascoli F
    FEBS Lett; 1997 May; 408(1):85-8. PubMed ID: 9180274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitors.
    Kam CM; Hernandez MA; Patil GS; Ueda T; Simmons WH; Braganza VJ; Powers JC
    Arch Biochem Biophys; 1995 Feb; 316(2):808-14. PubMed ID: 7864637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophobic interactions control zymogen activation in the trypsin family of serine proteases.
    Hedstrom L; Lin TY; Fast W
    Biochemistry; 1996 Apr; 35(14):4515-23. PubMed ID: 8605201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of tryptase in bovine cutaneous and tumor mast cells.
    Welle MM; Proske SM; Harvima IT; Schechter NM
    J Histochem Cytochem; 1995 Nov; 43(11):1139-44. PubMed ID: 7560896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases.
    Grzesiak A; Helland R; Smalås AO; Krowarsch D; Dadlez M; Otlewski J
    J Mol Biol; 2000 Aug; 301(1):205-17. PubMed ID: 10926503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bovine tryptase: purification and characterization.
    Fiorucci L; Erba F; Ascoli F
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):483-90. PubMed ID: 1515079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine mast cell tryptase inactivation: effect of temperature.
    Erba F; Fiorucci L; Coletta M; Ascoli F
    Peptides; 1998; 19(3):437-43. PubMed ID: 9533631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and thermodynamic analysis of leech-derived tryptase inhibitor interaction with bovine tryptase and bovine trypsin.
    Erba F; Fiorucci L; Sommerhoff CP; Coletta M; Ascoli F
    Biol Chem; 2000 Nov; 381(11):1117-22. PubMed ID: 11154069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of active monomers from tetrameric human beta-tryptase.
    Fajardo I; Pejler G
    Biochem J; 2003 Feb; 369(Pt 3):603-10. PubMed ID: 12387726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent selective nonpeptidic inhibitors of human lung tryptase.
    Burgess LE; Newhouse BJ; Ibrahim P; Rizzi J; Kashem MA; Hartman A; Brandhuber BJ; Wright CD; Thomson DS; Vigers GP; Koch K
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8348-52. PubMed ID: 10411878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption.
    Thomas VA; Wheeless CJ; Stack MS; Johnson DA
    Biochemistry; 1998 Feb; 37(8):2291-8. PubMed ID: 9485375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes associated with the spontaneous inactivation of the serine proteinase human tryptase.
    Schechter NM; Eng GY; Selwood T; McCaslin DR
    Biochemistry; 1995 Aug; 34(33):10628-38. PubMed ID: 7654717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human mast cell tryptase tetramer: a fascinating riddle solved by structure.
    Sommerhoff CP; Bode W; Matschiner G; Bergner A; Fritz H
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):75-89. PubMed ID: 10708850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.
    Huang C; Li L; Krilis SA; Chanasyk K; Tang Y; Li Z; Hunt JE; Stevens RL
    J Biol Chem; 1999 Jul; 274(28):19670-6. PubMed ID: 10391906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional properties of Bos taurus tryptase: a search for a possible propeptide processing role.
    Fiorucci L; Pallaoro M; Erba F; Colombo AP; Rholam M; Cohen P; Ascoli F
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Jun; 120(2):239-45. PubMed ID: 9787793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug.
    Erba F; Fiorucci L; Pascarella S; Menegatti E; Ascenzi P; Ascoli F
    Biochem Pharmacol; 2001 Feb; 61(3):271-6. PubMed ID: 11172730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.